G Termination of pregnancy referral. G NHS provision of treatments for minor ailments. G NHS provision of long-term oral contraception via a PGD. G Rapid HIV testing. G Provision of SRH services via supplementary and independent prescribing. PCTs may commission enhanced services to: G Extend free NHS access to an OTC product (e.g. EHC). G Extend access for those who do not pay prescription charges (e.g. minor ailments such as thrush). G Extend choice by widening the local range of providers (e.g. chlamydia screening and treatment, long-term oral contraception). PCTs will specify the requirements for both pharmacies (e.g. location, premises, opening times) and for individual pharmacists (evidence of relevant continuing professional development, training or accreditation). While all enhanced services are locally commissioned, the level of pharmacist expertise they require is variable. For those that offer free access to products which are already available for sale to the public significant additional requirements may not be needed, but provision of services that extend the pharmacists' current role in SRH will be dependent on individual pharmacists successfully demonstrating their competence as required by their PCT.
Pharmacists may also practise at an advanced or specialist level within the field of SRH. Practitioners to emerge so far often work within specialist HIV services, and recently consultant pharmacists have also been appointed. From 2007, pharmacists who combine their generalist role with a specific specialty (like GPs) can be locally accredited by PCTs as pharmacists with special interests (PhwSIs), and a national framework 1 includes an exemplar in the field of SRH. This service model could allow a few pharmacists with substantial additional expertise in SRH to provide a more comprehensive local service, and also to participate in specialist networks and mentors and support their pharmacy colleagues.
What are the public's views?
Evaluation of pharmacy provision of SRH services to date 2,3 has highlighted common themes: public enthusiasm where this improves access and convenience, and acceptance of pharmacies as locations for service provision provided that they meet standards for confidentiality and privacy. Pharmacies have responded to this and over 75% now have a private consultation area or room. Pharmacists are required to keep confidential records of NHS care and apply Fraser guidelines for consultations with under-16-year-olds in the same way as other health professionals.
As more medicines and medical devices are available in pharmacies for purchase by the public new issues may arise. The recent Medicines and Healthcare products Regulatory Agency (MHRA) consultation on the reclassification of azithromycin 4 raised some new issues including those outlined below. G What additional training might pharmacists require to provide services linked to laboratories, and how might this be provided? G What links should be developed between a non-NHS service and local specialist services? G What form of partner notification and follow-up can be offered?
G Within a non-NHS service, can data on prevalence and follow-up for treatment be collated? G Will concerns about appropriate use of antibiotics be addressed?
The outcome of the consultation is not yet known but there are likely to be more applications of this nature in the future, which could have significant public support. Unless pharmacists become integrated into local SRH networks and develop relationships with specialists there is a risk that any new services could develop in isolation or without access to key local information. This would be to the detriment of both the providers and the public, and supports the need for this issue to be addressed as soon as possible.
How could services be developed in the future? Many commissioners and sexual health leads are keen to make more use of pharmacies and are considering pharmacy's potential role in their locality. Key issues and challenges in this regard are summarised in Table 1. A final challenge that we all face is that relating to exemption from prescription charges. As more STI services rightly move into community settings, the current position whereby STI exemptions cannot be claimed for FP10 prescriptions is very frustrating for everyone, not least the pharmacist who is expected to collect the charge. A solution to this problem is urgently needed.
Conclusion
Now is the time for SRH service commissioners and providers to embrace the potential contribution of pharmacy, and to develop a vision of how this might be developed. In the London boroughs of Lambeth and Southwark, a systemwide modernisation programme has incorporated pharmacy-based services at several levels within a future service model (Figure 1 ) and full details of this are available on the Lambeth and Southwark Sexual Health website. 5 Could this be a signpost to the future elsewhere?
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Pharmacy perspective
Open access to pharmacies. Majority of opening hours include Saturdays and some also include evenings and Sundays.
Community pharmacies have always played a major role in self-care, and are visited by the public more often than other services.
Some services may be included within the existing NHS contract (e.g. sexual health promotion campaign) if chosen by the PCT.
Formal learning through HEIs or the Centre for Pharmacy Postgraduate Education courses is widely available. Performance in new advanced level roles may need to be assessed through supervised practice.
Popularity with some hard to reach populations (e.g. partners for STI treatment; those for whom appointments are a barrier to access).
DH-led pilots are planned later in 2008, and also wider interest. Who for -new and/or repeat users?
Pharmacies can be commissioned to provide screening or treatment or both.
Pharmacy challenges
Sustainability re PGD services -need more locums and second pharmacists who are also accredited.
Despite this, NHS providers often overlook pharmacists and they may not be represented in key sexual health meetings or opportunities at PCT level.
Where workload shifts from other NHS providers to pharmacies (e.g. EHC) how can resources be freed up and allocated in line with patient preferences? 
